Charterhouse Capital Partners agrees £235.2m take-private deal for animal health firm Animalcare Group

UK animal health pharmaceuticals company Animalcare Group has agreed terms on a recommended £235.2 million acquisition by private equity firm Charterhouse Capital Partners, in a deal that will see the York-headquartered business delist from AIM and transition to private ownership.

According to Insider Media, the offer tructured through CCP Paw 2, a wholly-owned indirect subsidiary of funds managed or advised by Charterhouse represents a 36% premium to Animalcare's closing share price of 247 pence on 15 April 2026. Eligible shareholders will also have the option to reinvest proceeds by subscribing for units in a holding company indirectly owned by the Charterhouse funds, rather than taking the cash consideration.

Animalcare operates across approximately 165 animal health pharmaceutical brands spanning multiple markets and therapeutic areas, with core specialisms in pain management, anaesthetics and analgesics, fluid therapy, gastric ulcer treatment, non-antibiotic anti-infectives and dental products. Its portfolio addresses companion animals, equine and production animal health.

Charterhouse partner Haitham Nasri said the acquisition presented a compelling platform opportunity. "We are delighted to be announcing this recommended acquisition of Animalcare, an attractive business with unique characteristics as a global animal health pharmaceuticals platform. Jennifer and her team have built a very strong foundation and as we look to the next phase of Animalcare's growth, we will continue to provide the resources and strategic flexibility required to accelerate R&D investments for the long-term, make the required operational investments and pursue transformative M&A."

Animalcare chair Ed Torr said the board concluded unanimously that the deal serves shareholder interests. "The offer from Bidco provides Animalcare shareholders with immediate value certainty in cash at an attractive premium and, for eligible Animalcare shareholders, the option to retain an economic interest through the alternative offer."

Dig into the full details of the Charterhouse and Animalcare deal.